Geoff Smith

Geoff Smith is a seasoned leader in the biotechnology sector, currently serving as the CEO and Co-Founder of Syndex Bio since March 2022. In addition to this role, Smith is an Independent Board Member for various companies since September 2020 and previously held positions including Chair of the Scientific Advisory Board at DNA Script and Managing Director at CompendiumBio Limited. With extensive experience as a strategic and technical advisor for multiple startups in genomics and synthetic biology, Smith has been influential in the industry, having served as Chief Technology Advisor at HiFiBiO Therapeutics and held key roles at Depixus, GE Healthcare, and Touchlight Genetics. Smith’s notable contributions to Illumina include inventing the MiSeq platform and leading advancements that resulted in a significant reduction in sequencing costs. Academic credentials include a PhD and MA in Biochemistry and Natural Sciences from the University of Cambridge.